As of 2024-12-13, the Intrinsic Value of Dexcom Inc (DXCM) is
47.55 USD. This Dexcom valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 78.93 USD, the upside of Dexcom Inc is
-39.80%.
The range of the Intrinsic Value is 29.40 - 113.61 USD
47.55 USD
Intrinsic Value
Dexcom Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
29.40 - 113.61 |
47.55 |
-39.8% |
| DCF (Growth 10y) |
59.65 - 215.47 |
93.36 |
18.3% |
| DCF (EBITDA 5y) |
49.17 - 84.96 |
66.61 |
-15.6% |
| DCF (EBITDA 10y) |
78.23 - 138.00 |
106.28 |
34.7% |
| Fair Value |
43.57 - 43.57 |
43.57 |
-44.79% |
| P/E |
57.47 - 78.96 |
64.92 |
-17.8% |
| EV/EBITDA |
23.45 - 54.05 |
42.13 |
-46.6% |
| EPV |
2.10 - 4.05 |
3.08 |
-96.1% |
| DDM - Stable |
21.62 - 92.61 |
57.11 |
-27.6% |
| DDM - Multi |
46.28 - 153.32 |
71.00 |
-10.0% |
Dexcom Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
30,830.06 |
| Beta |
0.53 |
| Outstanding shares (mil) |
390.60 |
| Enterprise Value (mil) |
32,706.66 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.67% |
| Cost of Debt |
4.25% |
| WACC |
7.35% |